360 related articles for article (PubMed ID: 31493022)
21. Focal IgG4-related autoimmune pancreatitis with distal choledochal adenocarcinoma: a rare case report.
Wang H; Yao L; Wang L; Sun X; Huang B
BMC Gastroenterol; 2021 Nov; 21(1):421. PubMed ID: 34758732
[TBL] [Abstract][Full Text] [Related]
22. [Autoimmune pancreatitis versus pancreatic cancer].
Wessling J; Juchems M; Grenacher L; Schreyer AG
Radiologie (Heidelb); 2023 Dec; 63(12):886-893. PubMed ID: 37947862
[TBL] [Abstract][Full Text] [Related]
23. Meta-analysis of CT and MRI for differentiation of autoimmune pancreatitis from pancreatic adenocarcinoma.
Ha J; Choi SH; Byun JH; Kim KW; Kim SY; Kim JH; Kim HJ
Eur Radiol; 2021 May; 31(5):3427-3438. PubMed ID: 33146798
[TBL] [Abstract][Full Text] [Related]
24. Inflammatory mimickers of pancreatic adenocarcinoma.
Kothari K; Lopes Vendrami C; Kelahan LC; Shin JS; Mittal P; Miller FH
Abdom Radiol (NY); 2020 May; 45(5):1387-1396. PubMed ID: 31559473
[TBL] [Abstract][Full Text] [Related]
25. Systematic review and meta-analysis of MRI features for differentiating autoimmune pancreatitis from pancreatic adenocarcinoma.
Yoon SB; Jeon TY; Moon SH; Lee SM; Kim MH
Eur Radiol; 2022 Oct; 32(10):6691-6701. PubMed ID: 35486167
[TBL] [Abstract][Full Text] [Related]
26. Utility of pVHL, maspin, IMP3, S100P and Ki67 in the distinction of autoimmune pancreatitis from pancreatic ductal adenocarcinoma.
Hedegaard Jensen G; Mortensen MB; Klöppel G; Nielsen MFB; Nielsen O; Detlefsen S
Pathol Res Pract; 2020 May; 216(5):152925. PubMed ID: 32273198
[TBL] [Abstract][Full Text] [Related]
27. Strategy for differentiating autoimmune pancreatitis from pancreatic cancer.
Kamisawa T; Imai M; Yui Chen P; Tu Y; Egawa N; Tsuruta K; Okamoto A; Suzuki M; Kamata N
Pancreas; 2008 Oct; 37(3):e62-7. PubMed ID: 18815540
[TBL] [Abstract][Full Text] [Related]
28. Current Concepts and Diagnosis of IgG4-Related Pancreatitis (Type 1 AIP).
Kawa S
Semin Liver Dis; 2016 Aug; 36(3):257-73. PubMed ID: 27466795
[TBL] [Abstract][Full Text] [Related]
29. Pancreatic ductal adenocarcinoma with autoimmune pancreatitis-like histologic and immunohistochemical features.
Zhang X; Liu X; Joseph L; Zhao L; Hart J; Xiao SY
Hum Pathol; 2014 Mar; 45(3):621-7. PubMed ID: 24457081
[TBL] [Abstract][Full Text] [Related]
30. Radiomics model of dual-time 2-[
Liu Z; Li M; Zuo C; Yang Z; Yang X; Ren S; Peng Y; Sun G; Shen J; Cheng C; Yang X
Eur Radiol; 2021 Sep; 31(9):6983-6991. PubMed ID: 33677645
[TBL] [Abstract][Full Text] [Related]
31. Multifocal autoimmune pancreatitis: A retrospective study in a single tertiary center of 26 patients with a 20-year literature review.
Huang XM; Shi ZS; Ma CL
World J Gastroenterol; 2021 Jul; 27(27):4429-4440. PubMed ID: 34366614
[TBL] [Abstract][Full Text] [Related]
32. Autoimmune pancreatitis: Multimodality non-invasive imaging diagnosis.
Crosara S; D'Onofrio M; De Robertis R; Demozzi E; Canestrini S; Zamboni G; Pozzi Mucelli R
World J Gastroenterol; 2014 Dec; 20(45):16881-90. PubMed ID: 25493001
[TBL] [Abstract][Full Text] [Related]
33. Effective apparent diffusion coefficient parameters for differentiation between mass-forming autoimmune pancreatitis and pancreatic ductal adenocarcinoma.
Ren H; Mori N; Hamada S; Takasawa C; Mugikura S; Masamune A; Takase K
Abdom Radiol (NY); 2021 Apr; 46(4):1640-1647. PubMed ID: 33037891
[TBL] [Abstract][Full Text] [Related]
34. Autoimmune pancreatitis and IgG4-related sclerosing cholangitis.
Takuma K; Kamisawa T; Igarashi Y
Curr Opin Rheumatol; 2011 Jan; 23(1):80-7. PubMed ID: 21124090
[TBL] [Abstract][Full Text] [Related]
35. Comparison of diagnostic performance between CT and MRI in differentiating non-diffuse-type autoimmune pancreatitis from pancreatic ductal adenocarcinoma.
Lee S; Kim JH; Kim SY; Byun JH; Kim HJ; Kim MH; Lee MG; Lee SS
Eur Radiol; 2018 Dec; 28(12):5267-5274. PubMed ID: 29948075
[TBL] [Abstract][Full Text] [Related]
36. Imaging mimics of pancreatic ductal adenocarcinoma.
Gandhi NS; Feldman MK; Le O; Morris-Stiff G
Abdom Radiol (NY); 2018 Feb; 43(2):273-284. PubMed ID: 29038855
[TBL] [Abstract][Full Text] [Related]
37. Diagnosis of autoimmune pancreatitis: the Mayo Clinic experience.
Chari ST; Smyrk TC; Levy MJ; Topazian MD; Takahashi N; Zhang L; Clain JE; Pearson RK; Petersen BT; Vege SS; Farnell MB
Clin Gastroenterol Hepatol; 2006 Aug; 4(8):1010-6; quiz 934. PubMed ID: 16843735
[TBL] [Abstract][Full Text] [Related]
38. Use of MRI signal intensity ratio to differentiate between autoimmune pancreatitis and pancreatic ductal adenocarcinoma.
Lu S; Liang J; Liao S; Wu D; Wu F; Li H
Clin Radiol; 2022 Jan; 77(1):e84-e91. PubMed ID: 34756699
[TBL] [Abstract][Full Text] [Related]
39. Understanding autoimmune pancreatitis: Clinical features, management challenges, and association with malignancies.
Christodoulidis G; Kouliou MN; Koumarelas KE
World J Gastroenterol; 2024 Apr; 30(15):2091-2095. PubMed ID: 38681985
[TBL] [Abstract][Full Text] [Related]
40. The use of magnetic resonance elastography in differentiating autoimmune pancreatitis from pancreatic ductal adenocarcinoma: A preliminary study.
Shi Y; Cang L; Zhang X; Cai X; Wang X; Ji R; Wang M; Hong Y
Eur J Radiol; 2018 Nov; 108():13-20. PubMed ID: 30396645
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
